Biosimilars Video Resource Summary
Why Biosimilars Matter
This one-minute introductory video is intended for anyone interested in why biosimilars matter.
This is an educational biosimilars resource provided by Organon.
Like generic medicines, biosimilars have the potential to increase competition in the health care marketplace, potentionally lowering cost to the health care system and facilitating patient access. Biologics have addressed some of health care’s biggest challenges.
By adopting biosimilars, it's expected that the health care system could potentially save on costs and resources.
Biologics accounted for about 36% of all US prescription drug spending in 2018. And with more in the pipeline, that number is likely to rise.
The potential impact of biosimilars
By adopting biosimilars, it’s expected the health care system could potentially save on costs and resources. Some of these savings may be re-invested back into the health care system.
Additional Biosimilars Resources
FDA requires biosimilar and interchangeable biological products meet the Agency’s rigorous approval standards.